Bone Sonometry PMAs Need Supporting Data From Caucasian Females
This article was originally published in The Gray Sheet
Executive Summary
Patient databases used in support of premarket approval of bone densitometry/sonometry devices in assessing fracture risk should consist of Caucasian females 20-29, according to an FDA final guidance.